URGN

UroGen Pharma Ltd. [URGN] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

URGN Stock Summary

In the News

URGN Financial details

Company Rating
-
Market Cap
515.24M
Income
-102.24M
Revenue
82.71M
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
198
Optionable
No
Shortable
Yes
Earnings
09 May 2024
P/E
-4.52
Forward P/E
-
PEG
2.04
P/S
5.82
P/B
-11.24
P/C
-
P/FCF
-5.28
Quick Ratio
6.21
Current Ratio
7.06
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-3.73
EPS next Y
-
EPS next Q
-
EPS this Y
-25.89%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-6.24%
Revenue last 5Y
440.08%
Revenue Q/Q
12.84%
EPS Q/Q
5.88%
-
-
-
-
SMA20
-6.54%
SMA50
-4.17%
SMA100
-14.35%
Inst Own
-
Inst Trans
-
ROA
-54%
ROE
108%
ROC
-0.42%
Gross Margin
88%
Oper. Margin
-92%
Profit Margin
-135%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
8.69-24.13
52W High
-68.58%
52W Low
-5.75%
RSI
34.97
Rel Volume
8.85
Avg Volume
354.62K
Volume
3.14M
Perf Week
-27.36%
Perf Month
-24.3%
Perf Quarter
-36.69%
Perf Half Y
-31.7%
-
-
-
-
Beta
1.084
-
-
Volatility
1.38%, 1.02%
Prev Close
-5.4%
Price
7.54
Change
5.01%

Something similar

Top by Market Cap
Same Price Range